Trial intelligence / Profile preview

EMPIRE: Etanercept and Methotrexate in Early Inflammatory Arthritis

NCT01303874Phase 4Completed

Sponsor
University of Leeds
Start
Sep 2006
Primary completion
Nov 2010
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 4 trial of etanercept in inflammatory arthritis, rheumatoid arthritis (RA), sponsored by University of Leeds. Started Sep 2006; status: completed.

02

Drugs

etanercept
03

Conditions

inflammatory arthritisrheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT01303874.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01303874.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call